These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8020531)

  • 1. Effect modelling for drugs undergoing enterohepatic circulation.
    Höglund P; Ohlin M
    Eur J Drug Metab Pharmacokinet; 1993; 18(4):333-8. PubMed ID: 8020531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interpretation of area under the curve measurements for drugs subject to enterohepatic cycling.
    Shepard TA; Reuning RH; Aarons LJ
    J Pharm Sci; 1985 Feb; 74(2):227-8. PubMed ID: 3989699
    [No Abstract]   [Full Text] [Related]  

  • 3. Segmentally continuous input functions in linear multicompartment systems.
    Süverkrüp R
    J Pharm Sci; 1985 Feb; 74(2):136-41. PubMed ID: 3989681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug recirculation model with multiple cycles occurring at unequal time intervals.
    Plusquellec Y; Houin G
    J Biomed Eng; 1992 Nov; 14(6):521-6. PubMed ID: 1434577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-delay for two-compartment models used for study of enterohepatic circulation of drugs.
    Plusquellec Y; Bousquet L
    IEEE Trans Biomed Eng; 1984 Jun; 31(6):469-72. PubMed ID: 6735419
    [No Abstract]   [Full Text] [Related]  

  • 6. Estimating the fraction reabsorbed in drugs undergoing enterohepatic circulation.
    Tse FL; Ballard F; Skinn J
    J Pharmacokinet Biopharm; 1982 Aug; 10(4):455-61. PubMed ID: 7153875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic study of the enterohepatic circulation of acetaminophen glucuronide in rats.
    Watari N; Hanawa M; Iwai M; Kaneniwa N
    J Pharmacobiodyn; 1984 Nov; 7(11):811-9. PubMed ID: 6530646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of area under the curve for drugs subject to enterohepatic cycling.
    Shepard TA; Reuning RH; Aarons LJ
    J Pharmacokinet Biopharm; 1985 Dec; 13(6):589-608. PubMed ID: 3834073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of enterohepatic recirculation in drug disposition: cooperation and complications.
    Malik MY; Jaiswal S; Sharma A; Shukla M; Lal J
    Drug Metab Rev; 2016 May; 48(2):281-327. PubMed ID: 26987379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Excretion of drugs in bile in man].
    Terhaag B
    Pharmazie; 1980; 35(10):638-9. PubMed ID: 7454747
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetic analysis of concentration-time data obtained following administration of drugs that are recycled in the bile.
    Colburn WA
    J Pharm Sci; 1984 Mar; 73(3):313-7. PubMed ID: 6585546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A practical method for monitoring drug excretion and enterohepatic circulation in the rat.
    Tse FL; Ballard F; Jaffe JM
    J Pharmacol Methods; 1982 Mar; 7(2):139-44. PubMed ID: 7098496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population Pharmacokinetic Modelling of Morphine, Gabapentin and their Combination in the Rat.
    Papathanasiou T; Juul RV; Gabel-Jensen C; Kreilgaard M; Lund TM
    Pharm Res; 2016 Nov; 33(11):2630-43. PubMed ID: 27380190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of drugs subject to enterohepatic circulation.
    Chen HS; Gross JF
    J Pharm Sci; 1979 Jun; 68(6):792-4. PubMed ID: 458586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A reversible clearance model for the enterohepatic circulation of drug and conjugate metabolite pair.
    Semmes RL; Shen DD
    Drug Metab Dispos; 1990; 18(1):80-7. PubMed ID: 1970782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Gallbladder-Based Enterohepatic Circulation Model for Pharmacokinetic Studies.
    Okour M; Brundage RC
    Eur J Drug Metab Pharmacokinet; 2019 Aug; 44(4):493-504. PubMed ID: 30488336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A time-lag model for pharmacokinetics of drugs subject to enterohepatic circulation.
    Steimer JL; Plusquellec Y; Guillaume A; Boisvieux JF
    J Pharm Sci; 1982 Mar; 71(3):297-302. PubMed ID: 7069584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetic modelling of the enterohepatic recirculation of diclofenac and rofecoxib in rats.
    Huntjens DR; Strougo A; Chain A; Metcalf A; Summerfield S; Spalding DJ; Danhof M; Della Pasqua O
    Br J Pharmacol; 2008 Mar; 153(5):1072-84. PubMed ID: 18193075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accumulation and time to steady state for drugs subject to enterohepatic cycling: a stimulation study.
    Shepard TA; Gannaway DJ; Lockwood GF
    J Pharm Sci; 1985 Dec; 74(12):1331-3. PubMed ID: 4087202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug disposition and liver disease.
    Wilkinson GR; Schenker S
    Drug Metab Rev; 1975; 4(2):139-75. PubMed ID: 770104
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.